Quantum Surgical

Quantum Surgical is a French company focused on medical robotics and artificial intelligence, specializing in minimally invasive, robotic-assisted cancer treatment.

Founded in 2017 and headquartered in Montpellier, France, with an office in Miami, Florida, the company employs over 130 people. Quantum Surgical aims to enhance cancer care by providing standardized access to innovative treatments that improve precision and safety. The company's flagship product is the Epione® robotic percutaneous ablation platform, which assists physicians in the precise destruction of tumors without the need for open surgery. This platform integrates robotics and AI to guide and assess ablation procedures, targeting cancers in the abdomen, lungs, and bones. Quantum Surgical also offers interventional oncology solutions, cloud-based treatment planning, and advanced image-guided surgery technologies. Quantum Surgical primarily serves healthcare providers and medical institutions specializing in oncology, including top-tier hospitals and cancer centers. The company has received notable recognition, including the Prix Galien USA in 2022, and is actively expanding its global presence, particularly in Europe and the United States.